hepatocellular carcinoma

Open Access
Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog
SOOMIN KIM, YEJI KIM, SE EUN KIM and HA-JUNG KIM

In Vivo January 2023, 37 (1) 252-261; DOI: https://doi.org/10.21873/invivo.13075
Open Access
Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial
YANG-CHENG LEE, WEN-TSUNG HUANG, MING-YANG LEE, CHAO-JUNG TSAO and YIN-HSUN FENG

In Vivo January 2023, 37 (1) 454-460; DOI: https://doi.org/10.21873/invivo.13099
Open Access
Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization and its Impact on Overall Survival
MONIKA HAJKOVA, TOMAS ANDRASINA, PETRA OVESNA, TOMAS ROHAN, MAREK DOSTAL, VLASTIMIL VALEK, LENKA OSTRIZKOVA, STEPAN TUCEK, JIRI SEDO and IGOR KISS

In Vivo September 2022, 36 (5) 2332-2341; DOI: https://doi.org/10.21873/invivo.12964
You have access
The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular Carcinoma
AKIYOSHI KINOSHITA, NORIKO HAGIWARA, AKIYUKI OSAWA, TAKAFUMI AKASU, YOSHIHIRO MATSUMOTO, KAORU UEDA, CHISATO SAEKI, TSUNEKAZU OIKAWA, KAZUHIKO KOIKE and MASAYUKI SARUTA

In Vivo March 2022, 36 (2) 865-873; DOI: https://doi.org/10.21873/invivo.12775
You have access
Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems
HIRONOBU YANAGIE, MASASHI YANAGAWA, YASUYUKI MORISHITA, ATSUKO SHINOHARA, NOVRIANA DEWI, YASUMASA NONAKA, YOSHITAKA FURUYA, RYOUJI MIZUMACHI, YUUJI MURATA, HIROYUKI NAKAMURA, MINORU SUZUKI, YOSHINORI SAKURAI, HIROKI TANAKA, SHINICHIRO MASUNAGA, KOJI ONO, TAKUMICHI SUGIHARA, MASAYUKI NASHIMOTO, HARUO YAMAUCHI, MINORU ONO, JUN NAKAJIMA and HIROYUKI TAKAHASHI

In Vivo November 2021, 35 (6) 3125-3135; DOI: https://doi.org/10.21873/invivo.12607
You have access
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN and ELENA LAURA ILIESCU

In Vivo November 2021, 35 (6) 3377-3383; DOI: https://doi.org/10.21873/invivo.12636
You have access
Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization
HYO-CHEOL KIM, JIN WOO CHOI, MYUNGSU LEE, YOON JUN KIM, JIN CHUL PAENG and JIN WOOK CHUNG

In Vivo July 2021, 35 (4) 2305-2312; DOI: https://doi.org/10.21873/invivo.12504
You have access
Association Between Renal Adverse Effects and Mortality in Patients With Hepatocellular Carcinoma Treated With Lenvatinib
YOSHINOSUKE SHIMAMURA, KOKI ABE, TAKUTO MAEDA, TAKESHI MATSUI, ATSUSHI ISHIGURO and HIDEKI TAKIZAWA

In Vivo May 2021, 35 (3) 1647-1653; DOI: https://doi.org/10.21873/invivo.12423
You have access
Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma
MASAMICHI HAYASHI, SUGURU YAMADA, NAO TAKANO, YUKIYASU OKAMURA, HIDEKI TAKAMI, YOSHIKUNI INOKAWA, FUMINORI SONOHARA, NOBUTAKE TANAKA, DAI SHIMIZU, NORIFUMI HATTORI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA, MASAHIKO KOIKE and YASUHIRO KODERA

In Vivo May 2021, 35 (3) 1749-1760; DOI: https://doi.org/10.21873/invivo.12434
You have access
Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma
NORITAKA MATSUDA, NORIHIRO IMAI, TEIJI KUZUYA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO

In Vivo March 2021, 35 (2) 1185-1189; DOI: https://doi.org/10.21873/invivo.12367

Main menu

User menu

Search

hepatocellular carcinoma

Pages